Based on this review, clinical
guidance for prevention of RSV infections through the use of Palivizumab were formulated by expert opinion consensus for the purpose of determining the appropriate use of Palivizumab.Because of the heterogeneous nature and complexity of immunode ficiency disorders, however, these guidelines may not fully cover all of them equally well.